Association of Blood Biochemical Indexes and Antibiotic Exposure With Severe Immune-related Adverse Events in Patients With Advanced Cancers Receiving PD-1 Inhibitors

Association of Blood Biochemical Indexes and Antibiotic Exposure With Severe Immune-related Adverse Events in Patients With Advanced Cancers Receiving PD-1 Inhibitors

Some patients with cancer treated with programmed death 1 (PD-1) inhibitors experience immune-related severe adverse events (ir-SAEs), however, predictors are limited. The objective was to identify clinicopathologic features that may be associated with a higher ir-SAE risk. This was a nested case-co...

Full description

Bibliographic Details
Main Authors: Chen, C. (Author), Han, C. (Author), He, X. (Author), Jiang, N. (Author), Kong, C. (Author), Li, L. (Author), Li, Y. (Author), Song, X. (Author), Wang, X. (Author), Xu, J. (Author), Yin, L. (Author), Zhao, L. (Author), Zhu, X. (Author), Zong, D. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
adverse event
Anti-Bacterial Agents
antiinfective agent
case control study
Case-Control Studies
human
Humans
Immune Checkpoint Inhibitors
neoplasm
Neoplasms
prognosis
Prognosis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items